search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
COVER STORY


Global innovation with local expertise


Mindray’s vision of ‘better healthcare for all’ underpins its drive for innovation in patient monitoring, ultrasound and defibrillation, which is benefiting leading NHS hospitals across the UK. Through deeply embedded partnerships Mindray helps customers provide better outcomes for their patients by developing market-led solutions that are pushing the next generation of medical technology.


Mindray is now one of the leading global developers of medical technology, with an R&D network spanning the US, Europe, and China. With a local focus on patient monitoring, defibrillation and ultrasound in the UK, Mindray has comprehensive UK based support and provides innovative medical devices to a range of hospital departments, including emergency, perioperative and critical care.


The growth of Mindray in the UK has been unprecedented - in just 17 years it has become one of the top 3 monitoring providers to the NHS. This is testament to the quality and reliability of the products


and the personalised, flexible service provided by the UK team.


Innovation


Mindray is dedicated to empowering healthcare professionals through innovative, high-value solutions that return better outcomes for patients. Mindray’s living technology is built to keep pace with the ever-changing requirements of healthcare, to produce market-driven solutions that are pushing the next generation of technology around the globe.


Research and Development Mindray invests over 10% of its annual


revenue into R&D every year, which is demonstrated in the level of innovation and product quality customers have come to expect. By investing heavily in R&D, Mindray strives to own a range of core technologies and play a pioneering role, injecting fresh vigor, into the overall innovation of the healthcare industry.


The UK plays a key role in global R&D, which is demonstrated in some of the clinical innovations being built into new technology. For example, all Mindray monitors now include a National Early Warning Score 2 (NEWS2) tool, which helps NHS caregivers identify patient deterioration with more speed and accuracy.


Through its worldwide R&D centres, Mindray is constantly engaging with customers to gain valuable insights for product development. Listening to customers, both technical and clinical, enables Mindray to rapidly develop technologies - putting cutting- edge innovation within reach for all hospitals.


Quality


Quality is built into every aspect of Mindray’s solutions, from manufacture to service, and pervades everything the company does. This has enabled Mindray to build customer confidence in products “made in China” and now has a reputation for developing devices with industry-leading reliability, built to the quality standards expected by the most demanding healthcare environments. With ISO 9001:2015 & 14001:2015 quality and environmental certifications, Mindray UK has a systematic approach to improving the quality and sustainability of its


6 I WWW.CLINICALSERVICESJOURNAL.COM AUGUST 2019 VOLUME 18 l ISSUE 7 l AUGUST 2019 CSJ THE CLINICAL SERVICES JOURNAL


Interim workforces: The challenges


The best theatre size for different surgeries?


The new heart of connected monitoring


WWW.CLINICALSER VICESJOURNAL.COM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92